ACAD insider transactions
ACADIA Pharmaceuticals Inc. (ACAD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ACAD
- Director Baker Bros. Advisors Lp was granted 37,244 shares (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Harrigan Edmund converted options into 8,107 shares, increasing direct ownership by 23% to 43,148 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Ndu Adora converted options into 8,107 shares, increasing direct ownership by 33% to 32,908 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Daly James M converted options into 8,107 shares, increasing direct ownership by 201% to 12,148 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Brege Laura converted options into 8,107 shares, increasing direct ownership by 54% to 23,202 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Garofalo Elizabeth A. converted options into 8,107 shares, increasing direct ownership by 32% to 33,489 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Poole Jonathan converted options into 2,010 shares (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James sold $114,393 worth of shares (5,401 units at $21.18), decreasing direct ownership by 18% to 24,509 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 2,596 shares and sold $29,024 worth of shares (1,332 units at $21.79) as part of a pre-agreed trading plan, increasing direct ownership by 5% to 29,129 units (SEC Form 4) to satisfy withholding tax4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold $76,396 worth of shares (3,506 units at $21.79) as part of a pre-agreed trading plan and converted options into 6,815 shares, increasing direct ownership by 5% to 66,145 units (SEC Form 4) to cover withholding tax4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Schneyer Mark C.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Kihara James4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Thompson Elizabeth H.Z.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Rhodes Jennifer J4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Owen Adams Catherine4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Schneyer Mark C.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Kihara James4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Poole Jonathan4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 3 filed by new insider Poole Jonathan3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by ACADIA Pharmaceuticals Inc.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by ACADIA Pharmaceuticals Inc.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by EVP, CHIEF LEGAL OFFICER, SEC Rhodes Jennifer J4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by ACADIA Pharmaceuticals Inc.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by EVP, Chief Commercial Officer Garner Thomas4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by PRINCIPAL ACCOUNTING OFFICER Kihara James4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF LEGAL OFFICER, SEC Rhodes Jennifer J converted options into 12,944 shares and sold $162,491 worth of shares (6,950 units at $23.38), increasing direct ownership by 371% to 7,609 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 19,826 shares and sold $243,114 worth of shares (10,262 units at $23.69), increasing direct ownership by 22% to 53,338 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 7,932 shares and sold $96,754 worth of shares (4,084 units at $23.69), increasing direct ownership by 18% to 25,058 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Daly James M sold $670,983 worth of shares (30,000 units at $22.37), decreasing direct ownership by 88% to 4,041 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. was granted 6,815 shares and sold $82,728 worth of shares (3,498 units at $23.65), increasing direct ownership by 8% to 43,447 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Garofalo Elizabeth A. sold $41,560 worth of shares (1,600 units at $25.98), decreasing direct ownership by 6% to 25,382 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold $554,024 worth of shares (22,000 units at $25.18), decreasing direct ownership by 35% to 40,130 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Brege Laura sold $314,634 worth of shares (14,446 units at $21.78), decreasing direct ownership by 49% to 15,095 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Daly James M converted options into 9,387 shares, increasing direct ownership by 38% to 34,041 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Ndu Adora converted options into 9,387 shares, increasing direct ownership by 61% to 24,801 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Soland Daniel B converted options into 9,387 shares, increasing direct ownership by 27% to 44,041 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Garofalo Elizabeth A. converted options into 9,387 shares, increasing direct ownership by 53% to 26,982 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Harrigan Edmund converted options into 9,387 shares, increasing direct ownership by 37% to 35,041 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Brege Laura converted options into 9,387 shares, increasing direct ownership by 47% to 29,541 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Baker Bros. Advisors Lp was granted 32,428 shares (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James sold $90,000 worth of shares (4,000 units at $22.50), decreasing direct ownership by 16% to 20,395 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold $50,000 worth of shares (2,000 units at $25.00), decreasing direct ownership by 3% to 62,130 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 2,596 shares and sold $19,374 worth of shares (1,327 units at $14.60), increasing direct ownership by 6% to 23,526 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 6,815 shares and sold $51,071 worth of shares (3,498 units at $14.60), increasing direct ownership by 6% to 62,773 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 5,275 shares and sold $40,133 worth of shares (2,708 units at $14.82), increasing direct ownership by 5% to 59,456 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 2,010 shares and sold $15,235 worth of shares (1,028 units at $14.82), increasing direct ownership by 5% to 22,257 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 2,142 shares and sold $18,670 worth of shares (1,095 units at $17.05), increasing direct ownership by 5% to 21,275 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 6,178 shares and sold $54,066 worth of shares (3,171 units at $17.05), increasing direct ownership by 6% to 56,889 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by EVP, CHIEF LEGAL OFFICER, SEC Rhodes Jennifer J4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by EVP, Head of Research & Dev Thompson Elizabeth H.Z.4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Owen Adams Catherine4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Garofalo Elizabeth A. sold $89,673 worth of shares (4,919 units at $18.23), decreasing direct ownership by 22% to 17,595 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 840 shares and sold $9,481 worth of shares (475 units at $19.96), increasing direct ownership by 2% to 20,228 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 1,353 shares and sold $15,429 worth of shares (773 units at $19.96), increasing direct ownership by 1% to 53,882 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 4 filed by EVP, Chief Commercial Officer Garner Thomas4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- SEC Form 3 filed by new insider Garner Thomas3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, COO, HEAD OF COMMERCIAL Teehan Brendan converted options into 19,826 shares and sold $173,630 worth of shares (10,329 units at $16.81), increasing direct ownership by 18% to 62,105 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- PRINCIPAL ACCOUNTING OFFICER Kihara James converted options into 7,930 shares and sold $68,467 worth of shares (4,073 units at $16.81), increasing direct ownership by 24% to 19,863 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 19,826 shares and sold $172,454 worth of shares (10,259 units at $16.81), increasing direct ownership by 22% to 53,302 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
- Director Ndu Adora converted options into 4,381 shares, increasing direct ownership by 40% to 15,414 units (SEC Form 4)4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)